Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering.
Le Gall CM, van der Schoot JMS, Ramos-Tomillero I, Khalily MP, van Dalen FJ, Wijfjes Z, Smeding L, van Dalen D, Cammarata A, Bonger KM, Figdor CG, Scheeren FA, Verdoes M. Le Gall CM, et al. Among authors: wijfjes z. Bioconjug Chem. 2021 Feb 17;32(2):301-310. doi: 10.1021/acs.bioconjchem.0c00673. Epub 2021 Jan 21. Bioconjug Chem. 2021. PMID: 33476135 Free PMC article.
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
van Elsas MJ, van der Schoot JMS, Bartels A, Steuten K, van Dalen D, Wijfjes Z, Figdor CG, van Hall T, van der Burg SH, Verdoes M, Scheeren FA. van Elsas MJ, et al. Among authors: wijfjes z. Int J Mol Sci. 2022 Aug 5;23(15):8707. doi: 10.3390/ijms23158707. Int J Mol Sci. 2022. PMID: 35955841 Free PMC article.
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.
Le Gall C, Cammarata A, de Haas L, Ramos-Tomillero I, Cuenca-Escalona J, Schouren K, Wijfjes Z, Becker AMD, Bödder J, Dölen Y, de Vries IJM, Figdor CG, Flórez-Grau G, Verdoes M. Le Gall C, et al. Among authors: wijfjes z. J Immunother Cancer. 2022 Apr;10(4):e004309. doi: 10.1136/jitc-2021-004309. J Immunother Cancer. 2022. PMID: 35428705 Free PMC article.